EGFR and non-small cell lung carcinoma: Consistent with this type of scenario, Kurppa et al. reported that NSCLC DTP cells surviving EGFR-MEK dual inhibition do not derive from pre-existing primed clones, but they arise randomly from the mass population of untreated cells [89].